C. diff Toxin Levels After Antibiotic Treatment
Part of Infections clinical trials.
This study looks at levels of C. diff toxins in stool after standard antibiotic treatment. It aims to understand how toxins change during recovery, which may help improve future treatments for C. diff infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently being treated with antibiotics for a C. diff infection, or your doctor plans to start treatment.
- You have had a C. diff infection at least once in the past year.
- You will finish your antibiotic course within 5 days before your first study visit.
- You are not planning any other treatments for C. diff (like fecal transplant, probiotics, or other special therapies) during the 8-week study.
- You do not have any other serious health conditions (like severe diarrhea, Crohn's, ulcerative colitis, or an ostomy) that would interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if capsules containing fecal microbiota can prevent further Clostridioides difficile infections in people who have had at least two recurrences. If you've had multiple C. diff infections and your symptoms go away with antibiotics, this treatment might help keep them from coming back.
This trial compares three treatments for Clostridioides difficile infection (a severe diarrhea caused by bacteria) to see which works best and prevents it from coming back. It tests a fecal microbiota transplant (FMT, transferring healthy donor stool), fidaxomicin, and vancomycin, all given by mouth or tube.
This trial studies how Clostridioides difficile (C. diff) affects healthy people by intentionally giving a controlled dose. The goal is to understand the infection better and help develop future treatments or vaccines.
This study tests whether specific lifestyle changes during treatment for C. difficile infection (a serious gut bacteria infection) can help prevent it from coming back. You'll receive standard antibiotic treatment and follow a controlled diet while researchers track your recovery.
This Phase 1 study tests a stool-based treatment approach for people who keep getting C. difficile diarrhea that returns after antibiotics. The goal is to see whether the treatment is safe and works to stop future episodes.
This study looks at how gut bacteria change after a fecal transplant for recurrent C. diff infection. It helps researchers understand which bacteria help fight the infection and which might resist treatment.
Hear when a new Clostridioides Difficile Infection Recurrence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.